• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Roll-in experience from the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study.来自心血管结果与肾脏动脉粥样硬化病变(CORAL)研究的 roll-in 经验。
J Vasc Interv Radiol. 2014 Apr;25(4):511-20. doi: 10.1016/j.jvir.2013.09.018. Epub 2013 Dec 8.
2
Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.经皮腔内血管成形术/支架置入治疗肾血管平滑肌脂肪瘤:十年随访结果
J Vasc Surg. 2012 Feb;55(2):421-7. doi: 10.1016/j.jvs.2011.09.006. Epub 2011 Nov 23.
3
Nine-month results of the REFORM study: a prospective, single-arm, multicenter clinical study of the safety and effectiveness of the Formula™ balloon-expandable stent for treatment of renal artery stenosis.REFORM 研究的 9 个月结果:Formula™球囊扩张支架治疗肾动脉狭窄的安全性和有效性的前瞻性、单臂、多中心临床研究。
Catheter Cardiovasc Interv. 2013 Aug 1;82(2):266-73. doi: 10.1002/ccd.24481. Epub 2013 Mar 25.
4
Renal Artery Stent Outcomes: Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure Gradient.肾动脉支架置入术的结果:基线血压、狭窄严重程度及跨病变压力梯度的影响
J Am Coll Cardiol. 2015 Dec 8;66(22):2487-94. doi: 10.1016/j.jacc.2015.09.073.
5
Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.在粥样动脉硬化性肾动脉狭窄患者的支架血运重建术中进行线粒体保护(Elamipretide)的 2a 期临床试验。
Circ Cardiovasc Interv. 2017 Sep;10(9). doi: 10.1161/CIRCINTERVENTIONS.117.005487.
6
Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.肾动脉支架置入术治疗未控制高血压患者的收缩压显著降低:HERCULES 试验结果。
Catheter Cardiovasc Interv. 2012 Sep 1;80(3):343-50. doi: 10.1002/ccd.24449. Epub 2012 Jun 27.
7
Endovascular management of atherosclerotic renovascular disease: early results following primary intervention.动脉粥样硬化性肾血管疾病的血管内治疗:初次干预后的早期结果
J Vasc Surg. 2008 Sep;48(3):580-7; discussion 587-8. doi: 10.1016/j.jvs.2008.04.050.
8
Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.CORAL试验中动脉粥样硬化性肾动脉狭窄支架置入术对估算肾小球滤过率的影响及临床事件的预测因素
Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1180-1188. doi: 10.2215/CJN.10491015. Epub 2016 May 25.
9
Did renal artery stent placement fail in the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study or did the CORAL Study Fail Renal Artery Stent Placement? The CORAL roll-in experience and the CORAL trials.在肾动脉粥样硬化病变的心血管结局(CORAL)研究中,肾动脉支架置入失败了吗?还是CORAL研究让肾动脉支架置入失败了?CORAL纳入阶段的经验及CORAL试验。
J Vasc Interv Radiol. 2014 Apr;25(4):520-3; quiz 524. doi: 10.1016/j.jvir.2013.12.569.
10
Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years.西罗莫司洗脱与裸金属低轮廓支架用于肾动脉治疗(GREAT试验):6个月后的血管造影随访及2年的临床结果
J Endovasc Ther. 2007 Aug;14(4):460-8. doi: 10.1177/152660280701400405.

引用本文的文献

1
Real Data Applications of Learning Curves In Cardiac Devices and Procedures.学习曲线在心脏器械和手术中的实际数据应用
J Med Stat Inform. 2018 Feb 16;6. doi: 10.7243/2053-7662-6-2.
2
Integrating Computational and Biological Hemodynamic Approaches to Improve Modeling of Atherosclerotic Arteries.整合计算和生物学血流动力学方法,改进动脉粥样硬化血管建模。
Adv Sci (Weinh). 2024 Jul;11(26):e2307627. doi: 10.1002/advs.202307627. Epub 2024 May 5.
3
Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH).动脉粥样硬化性肾血管疾病:欧洲肾脏病最佳实践(ERBP)协会、欧洲高血压学会(ESH)高血压与肾脏工作组的临床实践文件
Nephrol Dial Transplant. 2023 Nov 30;38(12):2835-2850. doi: 10.1093/ndt/gfad095.
4
Renal artery stenting in the correct patients with atherosclerotic renovascular disease: time for a proper renal and cardiovascular outcome study?对合适的动脉粥样硬化性肾血管疾病患者进行肾动脉支架置入术:是时候开展一项恰当的肾脏和心血管结局研究了吗?
Clin Kidney J. 2022 May 12;16(2):201-204. doi: 10.1093/ckj/sfac140. eCollection 2023 Feb.
5
Six Decades of History of Hypertension Research at the University of Toledo: Highlighting Pioneering Contributions in Biochemistry, Genetics, and Host-Microbiota Interactions.六十年托莱多大学高血压研究史:重点介绍生物化学、遗传学和宿主-微生物相互作用方面的开创性贡献。
Curr Hypertens Rep. 2022 Dec;24(12):669-685. doi: 10.1007/s11906-022-01226-0. Epub 2022 Oct 27.
6
Percutaneous transluminal renal angioplasty of global kidney ischemia improves renal function and blood pressure.全球肾脏缺血的经皮腔内肾血管成形术可改善肾功能和血压。
Int J Cardiol Heart Vasc. 2020 Jan 30;27:100475. doi: 10.1016/j.ijcha.2020.100475. eCollection 2020 Apr.
7
Learning curve estimation in medical devices and procedures: hierarchical modeling.医疗器械与手术中的学习曲线估计:分层建模
Stat Med. 2017 Jul 30;36(17):2764-2785. doi: 10.1002/sim.7309. Epub 2017 May 3.
8
Approach to atherosclerotic renovascular disease: 2016.动脉粥样硬化性肾血管疾病的治疗方法:2016年。
Clin Kidney J. 2016 Oct;9(5):713-21. doi: 10.1093/ckj/sfw079. Epub 2016 Sep 16.
9
Stent sizing strategies in renal artery stenting: the comparison of conventional invasive renal angiography with renal computed tomographic angiography.肾动脉支架置入术中的支架尺寸选择策略:传统有创肾血管造影与肾计算机断层血管造影的比较
Postepy Kardiol Interwencyjnej. 2016;12(2):116-21. doi: 10.5114/aic.2016.59361. Epub 2016 May 11.
10
Renal artery stenosis: if and when to intervene.肾动脉狭窄:是否以及何时进行干预。
Curr Opin Nephrol Hypertens. 2016 Mar;25(2):144-51. doi: 10.1097/MNH.0000000000000202.

本文引用的文献

1
Renal angioplasty and stenting: is it still indicated after ASTRAL and STAR studies?肾血管成形术和支架置入术:在ASTRAL和STAR研究之后,它是否仍有指征?
J Cardiovasc Surg (Torino). 2010 Oct;51(5):701-20.
2
Renal artery stenting: lessons from ASTRAL (Angioplasty and Stenting for Renal Artery Lesions).肾动脉支架置入术:来自ASTRAL(肾动脉病变血管成形术和支架置入术)的经验教训
JACC Cardiovasc Interv. 2010 Jul;3(7):786-7. doi: 10.1016/j.jcin.2010.06.003.
3
Kiss my astral: one seriously flawed study of renal stenting after another.吻我的星界:关于肾动脉支架置入术的一项又一项严重有缺陷的研究。
Catheter Cardiovasc Interv. 2010 Feb 1;75(2):305-7. doi: 10.1002/ccd.22416.
4
Revascularization versus medical therapy for renal-artery stenosis.肾动脉狭窄的血运重建与药物治疗对比
N Engl J Med. 2009 Nov 12;361(20):1953-62. doi: 10.1056/NEJMoa0905368.
5
Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial.动脉粥样硬化性肾动脉狭窄和肾功能受损患者的支架置入:一项随机试验。
Ann Intern Med. 2009 Jun 16;150(12):840-8, W150-1. doi: 10.7326/0003-4819-150-12-200906160-00119. Epub 2009 May 4.
6
Embolic protection and platelet inhibition during renal artery stenting.肾动脉支架置入术中的栓子保护与血小板抑制
Circulation. 2008 May 27;117(21):2752-60. doi: 10.1161/CIRCULATIONAHA.107.730259. Epub 2008 May 19.
7
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.肾动脉狭窄合并收缩期高血压患者支架血管重建预防心血管和肾脏事件:CORAL试验的理论基础与设计
Am Heart J. 2006 Jul;152(1):59-66. doi: 10.1016/j.ahj.2005.09.011.
8
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.全国高血压防治联合委员会第七次报告:预防、检测、评估及治疗
Hypertension. 2003 Dec;42(6):1206-52. doi: 10.1161/01.HYP.0000107251.49515.c2. Epub 2003 Dec 1.
9
The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group.球囊血管成形术治疗动脉粥样硬化性肾动脉狭窄所致高血压的效果。荷兰肾动脉狭窄干预协作研究组。
N Engl J Med. 2000 Apr 6;342(14):1007-14. doi: 10.1056/NEJM200004063421403.
10
Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group.
J Hum Hypertens. 1998 May;12(5):329-35. doi: 10.1038/sj.jhh.1000599.

来自心血管结果与肾脏动脉粥样硬化病变(CORAL)研究的 roll-in 经验。

Roll-in experience from the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study.

机构信息

Vascular Disease Research Center, Rhode Island Hospital, Gerry 337, 593 Eddy Street, Providence, RI 02903.

Division of Cardiology, University of Toledo, Toledo, Ohio.

出版信息

J Vasc Interv Radiol. 2014 Apr;25(4):511-20. doi: 10.1016/j.jvir.2013.09.018. Epub 2013 Dec 8.

DOI:10.1016/j.jvir.2013.09.018
PMID:24325931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4815916/
Abstract

PURPOSE

To describe the experience and results from the roll-in phase of the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study.

MATERIALS AND METHODS

The CORAL roll-in database was used to describe the baseline characteristics of the patients in the roll-in cohort, all of whom underwent renal artery stent placement; to evaluate CORAL site performance; to compare estimates of lesion (stenosis) severity made by site interventionalists with the central CORAL angiographic core laboratory readings; and to report outcomes after renal artery stent placement. During the roll-in phase, 239 patients (mean age, 70.2 y ± 9.0; 49% male) underwent renal artery stent procedures. Angiographic core laboratory analysis of renal arteriograms was done, and participants were followed at 1 month and 9 months.

RESULTS

Major angiographic complications were identified in 28 (13%) subjects. Kidney function remained unchanged at the short (2-4 weeks) follow-up interval. Improvement in systolic blood pressure with use of distal embolic protection devices (n = 161) did not show any clinical benefit over nonuse of such devices (n = 78) in this small series. At 9 months, there were significantly more endpoints reported by site in subjects with bilateral renal artery stenosis (P = .01) and prior history of stroke (P = .03).

CONCLUSIONS

In the roll-in phase of the CORAL study, a significant number of angiographic complications were identified. No effect was seen on estimated glomerular filtration rate after renal artery stent placement, but systolic blood pressure decreased significantly.

摘要

目的

描述心血管结果与肾动脉粥样硬化病变(CORAL)研究的入组阶段的经验和结果。

材料和方法

使用 CORAL 入组数据库描述入组队列中所有接受肾动脉支架置入术的患者的基线特征;评估 CORAL 研究中心的表现;比较介入医生评估的病变(狭窄)严重程度与 CORAL 核心实验室的中心阅片结果;报告肾动脉支架置入术后的结果。在入组阶段,239 例患者(平均年龄 70.2 岁±9.0 岁;49%为男性)接受了肾动脉支架置入术。对肾动脉造影进行了核心实验室分析,并在 1 个月和 9 个月时进行了随访。

结果

28 例(13%)患者发生主要血管造影并发症。在短期(2-4 周)随访时,肾功能保持不变。在这项小系列研究中,使用远端栓塞保护装置(n=161)的收缩压改善并没有比不使用此类装置(n=78)显示出任何临床获益。9 个月时,双侧肾动脉狭窄(P=0.01)和既往中风史(P=0.03)的患者报告的终点明显更多。

结论

在 CORAL 研究的入组阶段,发现了大量的血管造影并发症。肾动脉支架置入后肾小球滤过率估计值没有变化,但收缩压显著下降。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c8c/4815916/bc287424a11f/nihms547810f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c8c/4815916/ba950b68a1ab/nihms547810f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c8c/4815916/bc287424a11f/nihms547810f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c8c/4815916/ba950b68a1ab/nihms547810f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c8c/4815916/bc287424a11f/nihms547810f2.jpg